https://www.selleckchem.com/pr....oducts/sch772984.htm
T lymphocyte mediated acute rejection is a significant complication following solid organ transplantation. Standard methods of monitoring for acute rejection rely on assessing histologic tissue damage but do not define the immunopathogenesis. Additionally, current therapies for rejection broadly blunt cellular immunity, creating a high risk for opportunistic infections. There is therefore a need to better understand the process of acute cellular rejection to help develop improved prognostic tests and narrowly targeted therapies. Throu
Like
Comment
Share
